Focus
csl
LATEST
CSL Delivers $2.9 Billion Profit, 110 Million Flu Vaccine Doses
CSL said developing new and better vaccines is a strategic priority for the company going forward.
|
CSL said developing new and better vaccines is a strategic priority for the company going forward.
